OSIR - Osiris Therapeutics, Inc.

Other OTC - Other OTC Delayed Price. Currency in USD
Income Statement
Balance Sheet
Cash Flow

Income Statement

All numbers in thousands
Total Revenue50,83525,6987,164
Cost of Revenue9,8866,8512,420
Gross Profit40,94918,8474,744
Operating Expenses
Research Development3,4144,3304,059
Selling General and Administrative44,51916,5287,038
Non Recurring---
Total Operating Expenses---
Operating Income or Loss-6,984-2,011-6,353
Income from Continuing Operations
Total Other Income/Expenses Net-1,77141449
Earnings Before Interest and Taxes-8,755-1,597-6,304
Interest Expense---
Income Before Tax-8,755-1,597-6,304
Income Tax Expense97-994-37
Minority Interest---
Net Income From Continuing Ops-8,852-603-6,267
Non-recurring Events
Discontinued Operations-1,11843,063-5,318
Extraordinary Items---
Effect Of Accounting Changes---
Other Items---
Net Income
Net Income-9,97042,460-11,585
Preferred Stock And Other Adjustments---
Net Income Applicable To Common Shares-9,97042,460-11,585